World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 44 4807 4448 64 62 89 6067

Javier Leceta publications per year

The chart shows the history of publications by Javier Leceta between 1981 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Javier Leceta published across 43 years, from 1981 to 2023, averaging 2.1 papers a year. Output peaked at 8 publications in 2006. 4 of the 91 publications appeared in the last two years.

No. of publications
2 4 6 8
Bar chart. Horizontal axis: year, 1981 to 2023. Vertical axis: number of publications, 0 to 8. Peak 8 publications in 2006. 1981: 6 publications 1982: 1 publication 1983: 2 publications 1984: 1 publication 1985: 2 publications 1986: 1 publication 1987: 1 publication 1988: 1 publication 1989: 2 publications 1990: 0 publications 1991: 1 publication 1992: 1 publication 1993: 1 publication 1994: 4 publications 1995: 0 publications 1996: 4 publications 1997: 0 publications 1998: 2 publications 1999: 7 publications 2000: 3 publications 2001: 3 publications 2002: 4 publications 2003: 4 publications 2004: 1 publication 2005: 5 publications 2006: 8 publications 2007: 2 publications 2008: 3 publications 2009: 1 publication 2010: 2 publications 2011: 1 publication 2012: 2 publications 2013: 1 publication 2014: 3 publications 2015: 2 publications 2016: 2 publications 2017: 1 publication 2018: 1 publication 2019: 0 publications 2020: 0 publications 2021: 1 publication 2022: 2 publications 2023: 2 publications
1981 2023

91 publications in total across all disciplines

View publications per year as a table
Javier Leceta: publications per year, 1981 to 2023
Year Publications
1981 6
1982 1
1983 2
1984 1
1985 2
1986 1
1987 1
1988 1
1989 2
1990 0
1991 1
1992 1
1993 1
1994 4
1995 0
1996 4
1997 0
1998 2
1999 7
2000 3
2001 3
2002 4
2003 4
2004 1
2005 5
2006 8
2007 2
2008 3
2009 1
2010 2
2011 1
2012 2
2013 1
2014 3
2015 2
2016 2
2017 1
2018 1
2019 0
2020 0
2021 1
2022 2
2023 2
Total 91
Download as CSV

Javier Leceta publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Javier Leceta sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 82–91 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 89 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40 89
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Javier Leceta D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Javier Leceta sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 44–45 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157 44
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Javier Leceta is affiliated with the Complutense University of Madrid in Spain. Their research concentrates on immunology and microbiology, with particular emphasis on fields such as immunology, microbiology, oncology, cellular and molecular neuroscience, and molecular biology.

The scientist's work covers a range of topics primarily related to immune responses and inflammation, antimicrobial peptides and activities, peptidase inhibition and analysis, neuropeptides and animal physiology, immune cell function and interaction, inflammasomes and immune disorders, as well as autoimmune and inflammatory disorders research.

Recent publications by Javier Leceta include:

  • Editorial: Immunoregulation at mucosal surfaces (2022) in Frontiers in Immunology
  • Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune Arthritis (2021) in Frontiers in Immunology
  • Editorial: Overcoming challenges in mucosal immunity: 2022 (2023) in Frontiers in Immunology
  • Editorial: Community series in immunoregulation at mucosal surfaces volume II (2023) in Frontiers in Immunology

Javier Leceta frequently publishes in the journal Frontiers in Immunology, contributing to multiple articles in this venue.

The scientist collaborates with colleagues including S. Jordan, Christoph S. N. Klose, Rosa del Campo, Marina Garín, and Carmen Conde.

Best Publications

  • Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.

    Mario Delgado;Catalina Abad;Carmen Martinez;Javier Leceta

  • Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

    Catalina Abad;Carmen Martinez;Maria G. Juarranz;Alicia Arranz

  • Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6

    Mario Delgado;Mario Delgado;Carmen Martinez;David Pozo;Juan R. Calvo

  • Immunology of VIP: A Review and Therapeutical Perspectives

    R.P. Gomariz;C. Martinez;C. Abad;J. Leceta

  • Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.

    M Delgado;C Abad;C Martinez;M G Juarranz

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.

    Mario Delgado;Mario Delgado;David Pozo;Carmen Martinez;Javier Leceta

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages.

    Carmen Martínez;Mario Delgado;David Pozo;Javier Leceta

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.

    Mario Delgado;Javier Leceta;Doina Ganea

  • PACAP in Immunity and Inflammation

    Mario Delgado;Catalina Abad;Cartmen Martinez;M Guillermo Juarranz

  • Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis

    Yasmina Juarranz;Catalina Abad;Carmen Martinez;Alicia Arranz

  • VIP-PACAP system in immunity: new insights for multitarget therapy.

    R.P. Gomariz;Y. Juarranz;C. Abad;A. Arranz

  • Regulation of VIP production and secretion by murine lymphocytes

    Carmen Martinez;Mario Delgado;Catalina Abad;Rosa P Gomariz

  • Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor

    Carmen Martinez;Catalina Abad;Mario Delgado;Alicia Arranz

  • Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis

    Yossan-Var Tan;Catalina Abad;Robert Lopez;Hongmei Dong

  • Immunobiology of vasoactive intestinal peptide (VIP)

    David Pozo;Mario Delgado;Carmen Martı́nez;Juan M Guerrero

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.

    Mario Delgado;Javier Leceta;Rosa P. Gomariz;Doina Ganea

  • Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Collagen-Induced Arthritis: An Experimental Immunomodulatory Therapy

    Catalina Abad;Carmen Martinez;Javier Leceta;Rosa P. Gomariz

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis.

    Mario Delgado;Elvira Garrido;Carmen Martinez;Javier Leceta

  • Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock.

    Mario Delgado;Rosa P. Gomariz;Carmen Martinez;Catalina Abad

  • Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP

    Rosa P. Gomariz;Alicia Arranz;Catalina Abad;Marta Torroba

  • Receptors and Transcriptional Factors Involved in the Anti‐Inflammatory Activity of VIP and PACAP

    Javier Leceta;Rosa P. Gomariz;Carmen Martinez;Catalina Abad

Frequent Co-Authors

Rosa P. Gomariz
Rosa P. Gomariz Complutense University of Madrid
Carmen Martinez Mora
Carmen Martinez Mora Complutense University of Madrid
Mario Delgado
Mario Delgado Spanish National Research Council
Agustín G. Zapata
Agustín G. Zapata Complutense University of Madrid
Doina Ganea
Doina Ganea Temple University
Juan R. Calvo
Juan R. Calvo University of Seville
Mario Mellado
Mario Mellado Spanish National Research Council
Carolina Tafalla
Carolina Tafalla Spanish National Research Council
James A. Waschek
James A. Waschek University of California, Los Angeles
José Miguel Rodríguez-Frade
José Miguel Rodríguez-Frade Spanish National Research Council

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, online nursing degrees such as Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs offer valuable interdisciplinary connections. Many top programs provide excellent clinical experiences, making online pmhnp programs with clinical placement a key consideration for practical training alongside theoretical study.

Cost can be a major factor in pursuing further education. Fortunately, there are accessible options like the cheapest pmhnp certificate programs that help aspiring nurse practitioners enter mental health and immunology-related fields without significant financial burden.

Understanding potential earnings is equally important. Resources highlighting dnp salary transparency provide clear insights into salary expectations across states, helping students make informed decisions about their career paths within healthcare specialties linked to immunology.

For nurses wanting to expand their expertise, pathways such as acute care nurse practitioner programs offer opportunities to move from family practice to acute care settings. This transition can open doors to working in immunology-focused environments like hospitals and research centers, contributing significantly to patient care and disease management.

Best Scientists Citing Javier Leceta

Trending Scientists

Recently Published Articles